Clinical trial
Pharmacodynamic Effects of Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion in Patients Undergoing Percutaneous Coronary Intervention
NCT01919723 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacodynamic Effects of Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion in Patients Undergoing Percutaneous Coronary Intervention
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- December 31, 2015
- Enrollment
- 70 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.